LANCASTER, Calif. -- (Business Wire)

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Walt Woltosz, Chairman and Chief Executive Officer, and Ted Grasela, President, will attend The Benchmark Company, LLC’s Micro Cap Discovery Conference on Thursday, Dec. 11, 2014. The one-on-one conference will be held at The Palmer House Hilton, 17 E. Monroe St., Chicago, IL, from 8 a.m. to 2:30 p.m. Please email slp@haydenir.com or contact your Benchmark representative to schedule a one-on-one meeting.

For more information about the conference, visit http://www.benchmarkcompany.com/conference.php.

About The Benchmark Company, LLC

Headquartered in New York with 11 offices coast to coast, The Benchmark Company, LLC is an institutional brokerage firm that provides Research, Sales, Trading and Investment Banking services to public companies and their investors.

About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. Simulations Plus also recently acquired Cognigen Corporation of Buffalo, NY, adding top-quality clinical trial data analysis to our offerings, more than doubling our staff from 30 to 65, adding nearly 50% to revenues and expecting to increase earnings in the coming fiscal year that began September 1. The Company is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol “SLP.” Cognigen Corp is located in Buffalo, New York. For more information, visit our Web site at www.simulations-plus.com.

Contacts:

Simulations Plus Investor Relations
Ms. Renee Bouche, 661-723-7723
renee@simulations-plus.com
or
Hayden IR
Mr. Cameron Donahue, 651-653-1854
cameron@haydenir.com

Source: Simulations Plus, Inc.